Since 2016, annual updates of the HIV Investment Case set out to determine the optimal package of HIV interventions in South Africa, with the aim improve allocative efficiency of HIV funding from the three main sources- the South African government, PEPFAR and the Global Fund. The 2021 HIV Investment Case had the following central additions: For the 95% retention scenario in, we included a hypothetical ART retention intervention that aimed at reaching the UNAIDS target of 95% ART coverage. We also added an optimised package of HIV self-test distribution models, based on our previous work on the cost-effectiveness of HIV self-testing.
HE2RO staff involvedDr Gesine Meyer-Rath Lise Jamieson Dr. Jacqui Miot
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.